Intravenous-to-oral conversion therapy for antimicrobials
- PMID: 22346475
- PMCID: PMC3250842
- DOI: 10.1155/1994/428375
Intravenous-to-oral conversion therapy for antimicrobials
References
-
- Kunin CM. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis. 1985;151:388–98. - PubMed
-
- Hess DA, Mahoney CD, Johnson PN, et al. Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents. Am J Hosp Pharm. 1990;47:585–91. - PubMed
-
- Guglielmo BJ, Brooks GF. Antimicrobial therapy: Cost-benefit considerations. Drugs. 1989;38:473–80. - PubMed
-
- Quintiliani R, Nightingale CH. Antimicrobials and therapeutic decision making: A historical perspective. Pharmacotherapy. 1991;11:65–135. - PubMed
-
- Ramirez J, Srinath L, Akee S, Raff M. Switch therapy with oral ceflxime after intravenous third generation cephalosporin for the treatment of community-acquired pneumonia. 18th International Congress of Chemotherapy; Stockholm, Sweden. 1993. (Abst 1375)
LinkOut - more resources
Full Text Sources